2nd Quarter - Amendment

XOMA CORPORATION (FKA XOMA (US) LLC) for XOMA CORPORATION (FKA XOMA (US) LLC)

Firm
Client
Income
—
Expenses
$150,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report Jul 21, 2008 $16,210 Replaced
2nd Quarter - Amendment (this page) Oct 16, 2008 $150,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Defense DEF

Issues regarding biotechnology defense generally and specifically regarding national security; Issues regarding the HHS BARDA program and funding; Issues regarding countermeasure stockpiling.

LobbyistCovered position, as disclosed
STEVEN B ENGLE —
PATRICK JEROME SCANNON —
ROBERT TENEROWICZ —

Contacted: Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Defense, Dept of (DOD); Homeland Security, Dept of (DHS)

Medical/Disease Research/Clinical Labs MED

Issues regarding anti-botulism toxin.

LobbyistCovered position, as disclosed
DAN CAFARO —
STEVEN B ENGLE —
PATRICK JEROME SCANNON —
ROBERT TENEROWICZ —

Contacted: SENATE; Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Homeland Security, Dept of (DHS); Health & Human Services, Dept of (HHS); Defense, Dept of (DOD)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.